A 28 year old patient with ocular myasthenia for 2y gave birth to a baby with diaphragmatic weakness. Following delivery the mother developed severe weakness of the diaphragm and required assisted ventilation. The baby recovered spontaneously and the mother responded to treatment with plasma exchange and immunosuppression. Neither mother nor baby responded to anticholinergic drugs and in neither serum were acetyl choline receptor antibodies detected.
Introduction
Myasthenia gravis is an auto-immune disease characterized by fatiguable muscle weakness. The number of functioning acetyl choline receptors (AChR) at the neuromuscular junction is reduced because of destruction by IgG auto-antibodies (anti-AChR) (Drachman, 1978) . A clinical diagnosis of myasthenia may be confirmed by (1) a positive test performed with edrophonium chloride; (2) the presence of anti-AChR in the patient's serum; and (3) electromyography (EMG) of affected muscle which shows decrementing motor action potentials in response to repetitive nerve stimulation; single fibre electromyography is also useful to show 'jitter' which is a feature of defective neuromuscular transmission.
We describe a patient with myasthenia gravis in whom anti-AChR were not found, and in whom the muscle weakness was atypical in that it was localized to the diaphragm and in that it did not respond to anticholinergic drugs. The problems of establishing a diagnosis were therefore considerable. The patient gave birth to a baby who was affected by transient neonatal myasthenia, in whom the weakness was also confined to the diaphragm and who required assisted ventilation for over 2 weeks. Following delivery, the mother became increasingly dyspnoeic especially when lying flat. On day 12 post partum her vital capacity had fallen to 400 ml standing and was unrecordable when supine. Blood gases revealed pH 7.25, Po2 7.8 kPa (58.5 mm Hg) and Pco2 8.7 kPa (65.2mmHg). She did not respond to intravenous edrophonium and required intubation and intermittent positive pressure ventilation. Electrophysiological testing with repetitive nerve stimulation of the triceps muscle at a rate of 3/s showed no fatiguability. The diagnosis of myasthenia gravis was established by demonstrating reduced miniature end plate potentials (MEEP) on intercostal muscle biopsy (MEPP = 0.45 ± 0.09 mV, normal, more than 1 mV). Diaphragmatic weakness was demonstrated by measuring transdiaphragmatic pressure during a maximal static inspiratory effort with gastric and oesophageal balloon catheters. The maximum pressure change was greatly reduced at 6 cm H20 (normal>-25cm H20). Despite the absence of demonstrable anti-AChR, plasma exchange was performed and treatment with azathioprine and prednisolone was commenced. Four days after the final plasma exchange she was able to breathe alone during the day but continued to require ventilatory support at night until 10 weeks post partum. Prior to discharge there was no demonstrable diaphragmatic weakness, ptosis or diplopia. Her vital capacity was 1.7 litres when supine and blood gases were normal.
Diaphragmatic fatiguability was also demonstrated in the baby who required ventilatory support for 18 d but then made a spontaneous recovery.
At follow up 15 months later, both the baby and mother were well. The mother had no demonstrable weakness and her only treatment was azathioprine 150mg o.d. and prednisolone 15mg o.d. Since she remains asymptomatic consideration of thymectomy has been deferred.
Discussion
The diaphragm is the principal muscle of respiration being responsible for about 75% of inspiration during quiet breathing (Loh et al., 1977) . Diaphragmatic weakness results in considerable respiratory difficulty which is most marked in the supine position (McCredie et al., 1962) . Examination of the patient lying supine reveals paradoxical inward motion of the abdomen during inspiration and the patient's vital capacity, which may initially be low, falls by more than 25% in the supine position. Diaphragmatic dysfunction in this patient was confirmed by finding diminished pressure changes across the diaphragm during a maximum inspiratory effort (Pdi PI max), pleural and intra-abdominal pressures being measured simultaneously using oesophageal and gastric balloon catheters (Agostini & Rahn, 1960) . This patient's myasthenia was atypical in that the diaphragm was the only muscle significantly affected. In addition, the edrophonium test was negative and she did not respond to anti-cholinesterase drugs, antiAChR antibodies were not detected in the serum and the electromyogram was normal after repetitive nerve stimulation.
In patients with purely ocular myasthenia failure to respond to anticholinesterase drugs is well recognized but is unusual in a patient with more generalized myasthenia (Perlo et al., 1960) .
Since the diaphragm was principally affected in this patient, it is perhaps not surprising that electromyograms performed on unaffected peripheral muscles showed no fatiguability. The diagnosis of myasthenia was confirmed by finding a reduction in the size of miniature-end plate potentials (MEPP) on intercostal muscle biopsy (Lambert et al., 1976 Although anti-AChR antibodies were not detected in our patient, her response to plasma exchange and the transient signs in the infant supported the fact that a circulating factor was responsible. It would therefore seem probable that this patient had developed antibodies directed against the AChR binding site. Furthermore, the mother's condition deteriorated rapidly after delivery. This is often found in patients with myasthenia gravis and in patients with other diseases characterized by auto-antibodies such as immune thyroid disease (Davies & Weiss, 1981; Hardisty & Munro, 1983) .
Neonatal myasthenia gravis is a transient form of myasthenia gravis. It appears in about 20% of babies born to myasthenic mothers and is due to placental transfer of IgG antibodies to AChR from mother to baby (Warren & Planche, 1979) . Receptor antibodies are usually demonstrated in the blood of both mother and baby (Keesey et al., 1977; Donaldson et al., 1981) . As the titre falls the baby recovers. Mothers with low titres tend to have unaffected babies (Donaldson et al., 1981) . The onset of weakness usually takes several hours to develop and lasts on average 18 d. In this case, weakness was present at birth. The timing of symptoms possibly relates to maternal medication. The usual delay may be due to anticholinesterase drugs having been given to the mother which cross the placenta and therefore protect the baby for several hours after birth until the level of the drug diminishes. Our patient did not receive anticholinesterase drugs and this may explain why her baby was weak immediately at birth. Other unusual features in this infant were that he had no facial or ocular involvement, the weakness being confined to the diaphragm and that he did not respond to anticholinesterase drugs. mother and child. 
